Published in Women's Health Weekly, February 18th, 2010
"Due to its high inhibitory potency, this compound may serve as a promising novel lead for the design of new and potent modulators," wrote A. Pick and colleagues, University of Bonn.
The researchers concluded: "This adds a new structural class to the few known highly active BCRP inhibitors."
Pick and colleagues published their study in Bioorganic & Medicinal Chemistry Letters (Novel lead for potent inhibitors of breast cancer resistance protein (BCRP). Bioorganic &...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.